Related Experiment Video
Updated: Apr 5, 2026
07:35
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
Published on: December 26, 2016
43.3K
Does CSE1L Overexpression Affect Distant Metastasis Development in Breast Cancer?
Ulvi M Yuksel1, Ibrahim Turker, Gulay Dilek
1Department of Surgery, Oncology Training and Research Hospital, Ankara, Turkey.
Oncology Research and Treatment
|August 18, 2015
Summary
Nuclear CSE1L overexpression is linked to distant metastasis in breast cancer patients. This finding suggests CSE1L status could be a future prognostic tool for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- CSE1L (chromosome segregation 1-like) is homologous to yeast CSE1 and implicated in cancer invasion and metastasis.
- Understanding CSE1L's role in breast cancer progression is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the association between CSE1L expression and distant metastasis in breast cancer patients.
- To evaluate CSE1L as a potential prognostic biomarker for breast cancer metastasis.
Main Methods:
- Analyzed CSE1L expression using immunohistochemistry in tumor tissue from 71 breast cancer patients.
- Correlated CSE1L staining results with clinical characteristics, including distant metastasis, lymph node involvement, and nuclear grade.
Main Results:
- A significant correlation was observed between nuclear CSE1L overexpression and the occurrence of distant metastasis.
- Factors such as lymph node metastasis and nuclear grade also showed a relationship with distant metastasis.
- Patient age, tumor size, and hormone receptor status were comparable between groups with and without distant metastasis.
Conclusions:
- Nuclear CSE1L overexpression is significantly associated with distant metastasis in breast cancer.
- CSE1L status holds potential as a valuable prognostic indicator for predicting distant metastasis in breast cancer patients.
